Sorrento Therapeutics, Inc.
SRNE
$0.0009
-$0.0001-10.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 80.64M | 50.32M | 49.98M | 117.86M | 133.60M |
| Total Receivables | 32.73M | 26.52M | 24.47M | 24.19M | 24.72M |
| Inventory | 9.65M | 11.31M | 9.98M | 17.96M | 20.70M |
| Prepaid Expenses | 5.22M | 7.83M | 8.81M | 7.94M | 8.96M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.88M | 4.78M | 3.14M | 9.01M | 8.07M |
| Total Current Assets | 133.11M | 100.76M | 96.37M | 176.96M | 196.05M |
|
|
|||||
| Total Current Assets | 133.11M | 100.76M | 96.37M | 176.96M | 196.05M |
| Net Property, Plant & Equipment | 106.65M | 140.26M | 138.44M | 128.90M | 128.62M |
| Long-term Investments | 80.27M | 80.27M | 80.27M | 80.20M | 81.35M |
| Goodwill | 80.27M | 80.27M | 80.27M | 80.20M | 81.35M |
| Total Other Intangibles | 122.28M | 123.88M | 136.90M | 171.44M | 172.57M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.38M | 2.89M | 3.69M | 2.52M | 2.80M |
| Total Assets | 456.69M | 460.06M | 472.84M | 615.61M | 632.13M |
|
|
|||||
| Total Accounts Payable | 74.63M | 67.39M | 47.52M | 38.39M | 24.94M |
| Total Accrued Expenses | 101.43M | 80.16M | 66.64M | 88.96M | 74.21M |
| Short-term Debt | 75.00M | 30.00M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 58.41M | 33.69M | 30.17M | 66.28M | 37.22M |
| Total Finance Division Other Current Liabilities | 19.39M | 18.49M | 183.60M | 8.35M | 8.95M |
| Total Other Current Liabilities | 19.39M | 18.49M | 183.60M | 8.35M | 8.95M |
| Total Current Liabilities | 328.87M | 229.72M | 327.92M | 201.98M | 145.32M |
|
|
|||||
| Total Current Liabilities | 328.87M | 229.72M | 327.92M | 201.98M | 145.32M |
| Long-Term Debt | 21.74M | 21.40M | 19.13M | 17.80M | 83.07M |
| Short-term Debt | 75.00M | 30.00M | -- | -- | -- |
| Capital Leases | 52.45M | 84.46M | 85.21M | 84.13M | 84.32M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 251.60M | 251.91M | 62.25M | 181.50M | 183.66M |
| Total Liabilities | 654.65M | 587.48M | 494.51M | 485.41M | 496.37M |
|
|
|||||
| Common Stock & APIC | 2.04B | 2.02B | 1.99B | 1.92B | 1.83B |
| Retained Earnings | -2.19B | -2.10B | -1.96B | -1.74B | -1.65B |
| Treasury Stock & Other | -47.22M | -47.64M | -47.96M | -49.24M | -48.63M |
| Total Common Equity | -205.11M | -125.50M | -18.61M | 131.85M | 132.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -205.11M | -125.50M | -18.61M | 131.85M | 132.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 7.16M | -1.92M | -3.06M | -1.64M | 3.74M |
| Total Equity | -197.96M | -127.42M | -21.67M | 130.21M | 135.76M |
|
|
|||||